Recombinant Human Melan-A/MART-1 Protein Summary
Recombinant protein for Human Melan-A/MART-1
Source:E. coli
Amino Acid Sequence:(Q16655)
Method
>98% SDS-PAGE
E. coli
Recombinant Protein
MLANA
>95%, by SDS-PAGE
<0.1 ng/ug
Applications/Dilutions
18 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Packaging, Storage & Formulations
Store at -20 to -80C. Avoid freeze-thaw cycles.
Sterile filtered and lyophilized with no additives
Lyoph
>95%, by SDS-PAGE
Reconstitute in H2O to a concentration 0.1-1 mg/ml. The solution can then be further diluted to other aqueous solutions.
Alternate Names for Recombinant Human Melan-A/MART-1 Protein
- Antigen LB39-AA
- Antigen SK29-AA
- Mart 1 Melan A
- MART-1
- MART1MART-1
- MelanA
- Melan-A
- melanoma antigen recognized by T-cells 1
- MLANA
- Protein Melan-A
Background
MART-1 (also known as Melan-A) is a melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. Six other melanoma associated antigens recognized by autologous cytotoxic T cells include MAGE-1, Tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. SubCellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. Human MART-1 is purified by proprietary chromatographic techniques.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.